Yeah.

I don't want to put a way to describe it.

I run the Australian division of Main Pharma almost autonomously.

So there's very little influence from the US.

The business models are completely different, completely different.

And we generate about 20% of group revenue out of Australia.

So that's about 80 million a year that comes out of Australia.

It's a